Market Overview:
The global rotavirus infection therapeutics market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of rotavirus infections, rising demand for oral and injectable drugs, and growing number of online pharmacies. However, the high cost of treatment may restrain the growth of this market to some extent. The global rotavirus infection therapeutics market can be segmented on the basis of type into oral drug and injectable drug. The oral drug segment is expected to account for a larger share in terms of revenue in 2018 as compared to that generated by the injectable drug segment due its lower cost and easy availability. However, with technological advancements being made in the field of vaccine development, it is anticipated that demand for injectable drugs will increase significantly over the forecast period from 2018-2030.
Product Definition:
Rotavirus Infection Therapeutics is the use of medications or treatments to cure or prevent rotavirus infection. Rotavirus is a virus that can cause severe diarrhea, vomiting, and dehydration. The most common way to get rotavirus is by eating food or drinking water that has been contaminated with the virus. Rotavirus infection can be serious and even lead to death in some cases, especially in young children. Treatment for rotavirus usually involves rest, fluids, and antibiotics if there is also a bacterial infection present.
Oral Drug:
Oral drug is a medication which is given to patients by mouth. It may be in the form of tablets or capsules or as a liquid. The drug may be prescribed for acute as well as chronic conditions and it depends on the doctor’s decision, severity of illness and other factors.
Injiectable Drug:
Injiectable drug is a new term in the field of medicine and it means injectable drug. It’s an alternative to oral drugs which are not feasible for patients with severe vomiting or speech impairment. Injiectable drugs can be given through a vein by either the patient or healthcare professional, but it has to be done by a person in contact with the patient as they are very sensitive and have to be handled with care.
Application Insights:
Based on application, the global rotavirus infection therapeutics market is segmented into hospital pharmacies, retail pharmacies, online pharmacies and others. Hospital pharmacies held the largest share in 2017 owing to factors such as high usage of oral drugs for the treatment of diarrhea in children. Moreover, growing awareness about diarrhea management among parents is expected to fuel demand for rotavirus products from hospital pharmacies over the forecast period.
Retail pharmacy was one of the fastest-growing segments due to rising awareness among consumers regarding access to quality healthcare services at affordable prices. Furthermore, increasing incidences of travelers¢â‚¬â„¢ diarrhea are anticipated drive demand for travel size oral rehydration therapy (ORT) kits which are primarily manufactured by Roche and Medtronic amongst other manufacturers globally over next few years. This will provide a lucrative opportunity for product manufacturers during this forecast period especially if they have plans related with new product development or expansion activities in near future.
Regional Analysis:
North America held the largest revenue share in 2017. The region is expected to maintain its lead throughout the forecast period owing to increasing awareness about rotavirus vaccination and rising healthcare expenditure. In addition, growing generic drug manufacturing in this region is anticipated to further fuel market growth over the forecast period.
Asia Pacific is estimated to be one of the fastest-growing regions during the forecast years due to increasing government initiatives for immunization coupled with a high prevalence of undernutrition among children under 5 years old, which increases susceptibility towards disease transmission. Moreover, improving economic conditions are also likely boost demand for rotavirus infection therapeutics in emerging countries such as China and India over next few years.
Growth Factors:
- Increasing incidence of rotavirus infection across the globe
- Rising demand for better and effective therapeutics for rotavirus infection
- Emergence of new and advanced therapies for rotavirus infection
- Growing investments by key players in research and development of rotavirus therapy products
- Technological advancements in the field of diagnostics and therapeutics
Scope Of The Report
Report Attributes
Report Details
Report Title
Rotavirus Infection Therapeutics Market Research Report
By Type
Oral Drug, Injiectable Drug
By Application
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Companies
GlaxoSmithKline, Bharat Biotech, Curevac, Ology Bioservices, BioKangtai
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
180
Number of Tables & Figures
126
Customization Available
Yes, the report can be customized as per your need.
Global Rotavirus Infection Therapeutics Market Report Segments:
The global Rotavirus Infection Therapeutics market is segmented on the basis of:
Types
Oral Drug, Injiectable Drug
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GlaxoSmithKline
- Bharat Biotech
- Curevac
- Ology Bioservices
- BioKangtai
Highlights of The Rotavirus Infection Therapeutics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral Drug
- Injiectable Drug
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Rotavirus Infection Therapeutics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Rotavirus Infection Therapeutics is a company that develops and manufactures rotavirus vaccines.
Some of the key players operating in the rotavirus infection therapeutics market are GlaxoSmithKline, Bharat Biotech, Curevac, Ology Bioservices, BioKangtai.
The rotavirus infection therapeutics market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Rotavirus Infection Therapeutics Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Rotavirus Infection Therapeutics Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Rotavirus Infection Therapeutics Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Rotavirus Infection Therapeutics Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Rotavirus Infection Therapeutics Market Size & Forecast, 2018-2028 4.5.1 Rotavirus Infection Therapeutics Market Size and Y-o-Y Growth 4.5.2 Rotavirus Infection Therapeutics Market Absolute $ Opportunity
Chapter 5 Global Rotavirus Infection Therapeutics Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Rotavirus Infection Therapeutics Market Size Forecast by Type
5.2.1 Oral Drug
5.2.2 Injiectable Drug
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Rotavirus Infection Therapeutics Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Rotavirus Infection Therapeutics Market Size Forecast by Applications
6.2.1 Hospital Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Online Pharmacies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Rotavirus Infection Therapeutics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Rotavirus Infection Therapeutics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Rotavirus Infection Therapeutics Analysis and Forecast
9.1 Introduction
9.2 North America Rotavirus Infection Therapeutics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Rotavirus Infection Therapeutics Market Size Forecast by Type
9.6.1 Oral Drug
9.6.2 Injiectable Drug
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Rotavirus Infection Therapeutics Market Size Forecast by Applications
9.10.1 Hospital Pharmacies
9.10.2 Retail Pharmacies
9.10.3 Online Pharmacies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Rotavirus Infection Therapeutics Analysis and Forecast
10.1 Introduction
10.2 Europe Rotavirus Infection Therapeutics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Rotavirus Infection Therapeutics Market Size Forecast by Type
10.6.1 Oral Drug
10.6.2 Injiectable Drug
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Rotavirus Infection Therapeutics Market Size Forecast by Applications
10.10.1 Hospital Pharmacies
10.10.2 Retail Pharmacies
10.10.3 Online Pharmacies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Rotavirus Infection Therapeutics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Rotavirus Infection Therapeutics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Rotavirus Infection Therapeutics Market Size Forecast by Type
11.6.1 Oral Drug
11.6.2 Injiectable Drug
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Rotavirus Infection Therapeutics Market Size Forecast by Applications
11.10.1 Hospital Pharmacies
11.10.2 Retail Pharmacies
11.10.3 Online Pharmacies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Rotavirus Infection Therapeutics Analysis and Forecast
12.1 Introduction
12.2 Latin America Rotavirus Infection Therapeutics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Rotavirus Infection Therapeutics Market Size Forecast by Type
12.6.1 Oral Drug
12.6.2 Injiectable Drug
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Rotavirus Infection Therapeutics Market Size Forecast by Applications
12.10.1 Hospital Pharmacies
12.10.2 Retail Pharmacies
12.10.3 Online Pharmacies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Rotavirus Infection Therapeutics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Rotavirus Infection Therapeutics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Rotavirus Infection Therapeutics Market Size Forecast by Type
13.6.1 Oral Drug
13.6.2 Injiectable Drug
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Rotavirus Infection Therapeutics Market Size Forecast by Applications
13.10.1 Hospital Pharmacies
13.10.2 Retail Pharmacies
13.10.3 Online Pharmacies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Rotavirus Infection Therapeutics Market: Competitive Dashboard
14.2 Global Rotavirus Infection Therapeutics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 GlaxoSmithKline
14.3.2 Bharat Biotech
14.3.3 Curevac
14.3.4 Ology Bioservices
14.3.5 BioKangtai